« Back
Home /
Recombinant Human Galectin-7

Recombinant Human Galectin-7

Manufacturer	Cell Sciences
Category	Neuroscience Neural Lineage Markers Aging & Neurological Disorders Peptides & Proteins Recombinant Proteins
Type	Proteins
Specific against	Human
Amount	50 ug
Host	E.coli
Item no.	CS-CRG125B
eClass 6.1	34160400
eClass 9.0	42020190
Available
Biological Activity	Determined by its ability to agglutinate human red blood cells. The ED50 for the effect is typically 1-7 ug/ml.
Description	Galectin 7 belongs to growing family of evolutionary conserved animal lectins. Galectins consists of beta-galactoside binding lectins that contain homologous carbohydrate recognition domains (CRDs). Galectin has the ability to induce apoptosis of activated T-cells and T-leukaemia cell lines. Other activities include cell differentiation and inhibition activity of CD45 protein phosphatase activity. Galectin also binds beta-galactoside as well as CD45, CD3 and CD4. Recombinant Human Galectin 7 consists of 136 amino acid residues.
Endotoxin Level	< 0.1 ng/ug of Galectin 7
Formulation	Lyophilized without additives
Molecular Weight	15.4 kDa
Reconstitution	Centrifuge vial prior to opening . First add sterile distilled water to the vial to fully solubilize the protein to a concentration of 0.1-1.0 mg/ml. After complete solubilization of the protein, it can be further diluted to other aqueous solutions.
Storage and Stability	Store lyophilized protein at -20C to -80C. Reconstituted protein is stable for 1 week at 2-4C. For long term storage, aliquot and store at -20C. Avoid repeated freeze-thaw cycles .

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.